Biozenta has laid its foundation in year 2018 with a noble intention to provide critical care medicines at an affordable cost enabling every human being to live healthier, happier and more active life.

In short, span of time, Biozenta became a trusted name in global pharmaceutical industry as a leading manufacturer of best quality product in Oncology and critical care segment.

Biozenta is one of the leading and fastest growing pharmaceutical and life science group of companies with its presence in multiple therapy segment like Oncology/Cytotoxic and Critical Care/lifesaving medicines.

Biozenta strongly believe that research and innovation led product portfolio is the mainstay of organization. Biozenta keeps firm commitment towards quality and continuous innovation. Biozenta has established DSIR approved R&D set up for formulation as well as API to strengthen capability of innovative and research driven manufacturing facility.

Biozenta plant are equipped with state of art, WHO cGMP Certified, PICS approved, EU GMP approvable facilities located in one of the strategic pharmaceutical zone of Una, Himachal Pradesh. At an early stage, Biozenta Leadership identified the need for achieving self-sufficiency in formulation by vertically integrating its API Plant commissioned to cater API needs

Please have a glimpse on ultra-modern manufacturing facility dedicated for the production of Generic and Branded formulation in Oncology and Critical Care segment:

• Oncology Facility - Well equipped, Dedicated, completely isolated & separate unit at UNA, H.P, covers all the major dosage forms in Oncology/ Anti-cancer/ Cytotoxic range - Liquid Injectables, Lyophilized Injectables, Pre-filled Syringes (PFS) & Oral Solids-Tablets and Capsules.
• General Facility – Stand-alone & separate unit at UNA, H.P, covering all major dosage forms of Liquid Injectables, Lyophilized Injectable, Pre-filled Syringes (PFS) & Oral Solids - Tablets and Capsules.
• Active Pharmaceutical Ingredients Unit - Dedicated Oncology/Anti-cancer/Cytotoxic API and Intermediates facility located at UNA, H.P to make company self-sufficient with focus to improve the synthetic procedures, Quality & stability of the Raw materials.